Insiders who bought US$2.11m worth of Zenas BioPharma, Inc. (NASDAQ:ZBIO) stock in the last year have seen some of their losses recouped as the stock gained 12% last week. However, the purchase is ...

Zenas Biopharma pays an annual dividend of $0.05 per share and has a dividend yield of 0.5%. Zenas Biopharma pays out -1.4% of its earnings in the form of a dividend. As a group, “Biotechnology ...

Hansa Biopharma reported stronger-than-expected results for the first quarter of 2025, with earnings per share (EPS) significantly outperforming forecasts. The company posted an EPS of -0.55 ...

Lund, Sweden, 24 April 2025. Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced the appointment of Renée Aguiar-Lucander as Chief Executive Officer (CEO), effective immediately.

In this article, we are going to take a look at where Xeris Biopharma Holdings Inc. (NASDAQ:XERS) stands against other best multibagger penny stocks to buy according to billionaires. Penny stocks ...

TORONTO - Quantum BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company with a market capitalization of $16.67 million, announced today the appointment of Kevin Malone as an advisor to its ...

This summary is reviewed by TRD Staff. Grove Biopharma expanded to a 17,000-square-foot space at Trammell Crow's Fulton Labs after receiving $30 million in funding; it previously used shared space ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) pursuant and/or traceable to the registration statement and ...

Proceeds will be used to further advance Grove Biopharma’s proprietary platform and drive its lead oncology programs towards the clinic. Bionic Biologics represent a novel therapeutic modality ...